Homeβ€ΊSearchβ€ΊCURRENT PHARMACOLOGY REPORTS

CURRENT PHARMACOLOGY REPORTS

SPRINGERNATURE Β· GB Β· Est. 2015

ISSN2198-641XeISSN2198-641X
SJR Q3βœ“ WOS ESCIβœ“ Scopus / SJR
62
/ 100
Established
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS ESCI56
βœ“ Corroboration (1 more)+6
Total62
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
230
days submission β†’ published
measured Β· last 7 articles Β· accept 216d
Q3
SJR Rank
Top 75% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.499
H-Indexi
47
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.546
Total Worksi
442
Total Citationsi
8,719
2yr Mean Citednessi
2.29
Open Impact Factor alternative

Aims & Scope

This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central nervous system, cardiovascular disease, metabolic diseases, cancer and others.

General Information

Country / RegionGB
Primary LanguageEnglish
1st Year Published2015
Annual Volume~ 43 articles / year
StatusActive (last: 2026)
Total Publications442
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
SPRINGERNATURE
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2198-641X / 2198-641X
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
43
826
2019
40
1.6k
2020
22
460
2021
38
621
2022
41
237
2023
37
149
2024
50
136
2025
28
5
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

BiochemistryQ3
Drug DiscoveryQ3
GeneticsQ3
PharmacologyQ3

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Research Topics (OpenAlex)

Epigenetics and DNA MethylationGenomics, phytochemicals, and oxidative stressPhytochemicals and Antioxidant ActivitiesComputational Drug Discovery MethodsPharmacogenetics and Drug MetabolismNatural Antidiabetic Agents StudiesSARS-CoV-2 and COVID-19 ResearchRNA modifications and cancerCOVID-19 Clinical Research StudiesMicroRNA in disease regulation

Frequently asked questions about CURRENT PHARMACOLOGY REPORTS

Is CURRENT PHARMACOLOGY REPORTS a predatory journal?

PubScope has no integrity flags on record for CURRENT PHARMACOLOGY REPORTS: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 62/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of CURRENT PHARMACOLOGY REPORTS?

CURRENT PHARMACOLOGY REPORTS is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.29.

Is CURRENT PHARMACOLOGY REPORTS indexed in Scopus and Web of Science?

CURRENT PHARMACOLOGY REPORTS is indexed in Web of Science, Scopus.

What is the aims and scope of CURRENT PHARMACOLOGY REPORTS?

This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central ner

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref